Brief: PCI Biotech Granted New European Patent
Nov 16 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* REG-PCI BIOTECH: EUROPEAN PATENT FOR TREATMENT OF BILE
DUCT
CANCER WITH THE FIMACHEM TECHNOLOGY
* TODAY'S ANNOUNCED EUROPEAN PATENT SECURE PROTECTION UNTIL
2037
* PATENT APPLICATION IS STILL PENDING IN US AND KEY ASIAN
MARKETS.
Source text for Eikon: ID:nGNE3Tm0vV
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process